Intelligent Oxygen Therapy During Activities of Daily Living
Study Details
Study Description
Brief Summary
The aim of this study is to assess whether an auto-titrating oxygen system can maintain constant oxygen saturations (SpO2) in patients who are on long-term oxygen therapy (LTOT) during activities of daily living.
Currently LTOT is provided at a constant fixed-flow rate e.g. 2 litres per minute all the time after appropriate assessment. The flow rate is not changed during usual household activities but is increased for walking. A number of studies have investigated the SpO2 of patients on LTOT during the daytime in patients' homes. The results have shown that patients' SpO2 decreases intermittently whilst they are doing activities of daily living such as watching television, putting away the shopping, having a shower or bath and dressing and undressing. This is a problem as it can lead to breathlessness, increased stress on the heart and affect brain function. In order to correct the drop in SpO2 that patients experience during everyday activities, the investigators have developed an oxygen system, which can automatically change the amount of oxygen delivered depending on a patients' oxygen saturations - an auto-titrating oxygen system. In this study, patients on LTOT will be asked to simulate a series of activities of daily living twice: once whilst on their usual fixed-flow oxygen therapy and once on the auto-titrating oxygen system. The activities will be carried out in a hospital setting. During the activities, SpO2 will be recorded continuously. The main outcome of interest from the study will be the SpO2 throughout the study on fixed-flow oxygen and the auto-titrating oxygen system.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
N/A |
Detailed Description
Long-term oxygen therapy (LTOT) is prescribed for patients with stable severe hypoxemic respiratory failure according to specific criteria set out in different guidelines from international respiratory societies. The aim of LTOT is to maintain the resting partial pressure of oxygen (PO2) >60 mmHg or oxygen saturation (SpO2) >90%.
A number of studies have demonstrated that whilst at home, patients on LTOT experience episodes of intermittent hypoxia (SpO2 <90%) and spend significant amounts of time with SpO2 <90%. These episodes of desaturation occur most frequently during activities of daily living and may be harmful as they could lead to pulmonary hypertension, arrhythmias and ischaemic heart disease. Simply increasing the LTOT flow rate by 1 or 2 litres in one option but this exposed the patients to hyperoxaemia and the risk of hypercapnia. An another method optimising LTOT is to utilise an auto-titrating oxygen system. These system allow close control of SpO2 by automatically adjusting the flow of oxygen to match a target SpO2. At the Royal Brompton Hospital and Imperial College London, the investigators have developed our own auto-titrating oxygen system - called intelligent oxygen therapy (iO2t).
This system has been tested in patients with chronic obstructive pulmonary disease (COPD) and LTOT during a 6 minute walk test with promising results (ERS 2015).
The aim of this study is to investigate whether the intelligent oxygen therapy system can reduce intermittent hypoxia in patients on LTOT during simulated activities of daily living. Patients will be asked to a series of activities of daily living over a period of 1 hour including: washing, dressing, putting away shopping and cleaning. The patients will do these activities twice: once on their usual LTOT and once on the auto-titrating oxygen system in a cross-over design.
Study Design
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| Experimental: Activities of daily living on iO2t Patients will complete simulated activities of daily living on intelligent oxygen therapy (an auto-titrating oxygen system) |
Device: Intelligent oxygen therapy (an auto-titrating oxygen system)
This device is an auto-titrating oxygen system. The system is programmed to maintain a specific target SpO2 by automatically adjusting the oxygen flow rate. The system can deliver flow rates of 0-5 litres/minute.
|
| Active Comparator: Activities of daily living on LTOT Patients will complete activities of daily living on their usual long-term oxygen therapy. |
Device: Long-term oxygen therapy
This is the patients usual long-term oxygen therapy
|
Outcome Measures
Primary Outcome Measures
- The percentage of time spent with SpO2 <90% during the activities of daily living - 55 minutes [Calculated over the duration of the time the patient is carrying out activities of daily living (55 minutes)]
Secondary Outcome Measures
- Mean SpO2 during the activities of daily living - 55 minutes [Calculated over the duration of the time the patient is carrying out activities of daily living (55 minutes)]
- Mean Heart rate during the activities of daily living - 55 minutes [Calculated over the duration of the time the patient is carrying out activities of daily living (55 minutes)]
- Borg score for breathlessness and fatigue at the end of activities of daily living (55 minutes) [At the end of activities of daily living (55 minutes)]
- Total volume of oxygen delivered during simulated activities of daily living during the activities of daily living (55 minutes) [Calculated over the duration of the time the patient is carrying out activities of daily living (55 minutes)]
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Age >18 years
-
Currently on or eligible for LTOT for respiratory failure
Exclusion Criteria:
-
LTOT flow rate ≥4 litres per minute
-
Exacerbation of underlying lung disease in the past 4 weeks
-
Inability to understand English
-
Significant co-morbidities
-
Patients who lack capacity to consent
-
Pregnancy
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Royal Brompton and Harefield NHS Trust | London | United Kingdom | SW3 6NP |
Sponsors and Collaborators
- Imperial College London
- National Institute for Health Research, United Kingdom
- Royal Brompton & Harefield NHS Foundation Trust
Investigators
- Principal Investigator: Anita Simonds, FRCP, Royal Brompton & Harefield NHS Foundation Trust
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- 15IC2835